Search results
Covid-19 vaccines: serious adverse events explained
Pharmaceutical Technology· 3 days agoAdverse Events of COVID-19 Vaccines A total of 21 Covid-19 vaccines have been ...
MHRA approves Pfizer-BioNTech’s Comirnaty JN.1 vaccine
Pharmaceutical Technology· 17 hours agoThe vaccine stimulates the immune system to produce antibodies and blood cells against Covid-19....
Type 1 diabetes left out of Covid-19 conversation, but ripple effects are ongoing
Pharmaceutical Technology· 3 days agoAs diabetes diagnoses increase, it is crucial to note that individuals with diabetes are at a higher...
Biden completes fourth dose of PAXLOVID, COVID-19 symptoms have "improved meaningfully": US...
The Economic Times· 6 days agoWashington: US President Joe Biden, who was tested positive for COVID-19 early this week, has...
UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain - ET HealthWorld |...
The Economic Times· 1 day agoLondon: Britain's health regulator said on Wednesday it has authorised Pfizer and BioNTech's updated...
Covid-19 summer wave in US: 6 Ayurvedic herbs to boost immunity against the virus - Times of India
The Times of India· 3 days agoAs President Joe Biden tests positive for Covid-19 along with many other Americans, experts say it's...
Covid scare at Paris Olympics: Australian athlete isolated after testing positive
CNBC Awaaz· 3 days agoFour years ago Covid-19 pushed sports on the backfoot, forcing the Olympics to be held a year later...
1.1 mn excess deaths during Covid-19, 8 times more than govt figure: Study
Business Standard India· 6 days agoIn India, 1.19 million excess deaths occurred in 2020 during the Covid-19 pandemic, 17 per cent...
Long COVID puzzle pieces are falling into place - the picture is unsettling - ET HealthWorld
The Economic Times· 7 days agoWashington: Since 2020, the condition known as long COVID-19 has become a widespread disability...
A new generation of weight loss drugs could radically change healthcare
Semafor· 7 hours agoT Sales were down 20% in the first quarter of 2024 and its stock recently hit the lowest point in a...